secwatch.observer — SEC 8-K summary
======================================

Issuer:     TENAX THERAPEUTICS, INC. (TENX)
CIK:        0000034956
Form:       8-K
Filed at:   2023-06-13T23:59:59+00:00
Accession:  0001654954-23-007952
Event type: other_material
Sentiment:  negative
Materiality: 0.50
LLM model:  deepseek-v4-flash:cloud@v2

Tenax shareholders reject reverse stock split and stock plan amendment; directors elected
--------------------------------------------------------------------------------

- All seven director nominees elected: June Almenoff, Michael Davidson, Declan Doogan, Christopher Giordano, Robyn Hunter, Gerald Proehl, Stuart Rich.
- Reverse stock split proposal failed: 5,560,628 for, 5,268,941 against, 112,897 abstain.
- Stock incentive plan amendment (increase by 2.75M shares) failed: 2,775,491 for, 4,415,521 against, 262,926 abstain, 3,488,528 broker non-votes.
- Ratification of Cherry Bekaert as auditor approved: 9,331,120 for, 1,014,740 against, 596,606 abstain.
- Adjournment proposal approved (7,279,249 for) but not used; meeting concluded without adjournment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/34956/000165495423007952/0001654954-23-007952-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/34956/000165495423007952/tenx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-007952

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer